224 related articles for article (PubMed ID: 8347498)
21. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
[TBL] [Abstract][Full Text] [Related]
22. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.
Suchy BK; Sarafoff M; Kerler R; Rabes HM
Cancer Res; 1989 Dec; 49(23):6781-7. PubMed ID: 2684400
[TBL] [Abstract][Full Text] [Related]
23. Expression of the proto-oncogenes c-fos and c-myc in mdx dystrophic mouse muscle.
Veal EA; Jackson MJ
Biochem Soc Trans; 1995 Feb; 23(1):131S. PubMed ID: 7758695
[No Abstract] [Full Text] [Related]
24. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial.
Augenlicht LH; Wadler S; Corner G; Richards C; Ryan L; Multani AS; Pathak S; Benson A; Haller D; Heerdt BG
Cancer Res; 1997 May; 57(9):1769-75. PubMed ID: 9135021
[TBL] [Abstract][Full Text] [Related]
25. Telomerase activity in colorectal cancer and its relationship to bcl-2 expression.
Iida A; Yamaguchi A; Hirose K
J Surg Oncol; 2000 Apr; 73(4):219-23. PubMed ID: 10797335
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of c-myc mRNA expression assessed by semi-quantitative RT-PCR in patients with colorectal cancer.
Kakisako K; Miyahara M; Uchino S; Adachi Y; Kitano S
Oncol Rep; 1998; 5(2):441-5. PubMed ID: 9468576
[TBL] [Abstract][Full Text] [Related]
27. Expression of c-met proto-oncogene in primary colorectal cancer and liver metastases.
Fujita S; Sugano K
Jpn J Clin Oncol; 1997 Dec; 27(6):378-83. PubMed ID: 9437998
[TBL] [Abstract][Full Text] [Related]
28. Stage III & IV colon and rectal cancers share a similar genetic profile: a review of the Oregon Colorectal Cancer Registry.
Gawlick U; Lu KC; Douthit MA; Diggs BS; Schuff KG; Herzig DO; Tsikitis VL
Am J Surg; 2013 May; 205(5):608-12; discussion 612. PubMed ID: 23592171
[TBL] [Abstract][Full Text] [Related]
29. The relation of ras family oncogene expression to conventional staging criteria and clinical outcome in colorectal carcinoma.
Kerr IB; Spandidos DA; Finlay IG; Lee FD; McArdle CS
Br J Cancer; 1986 Feb; 53(2):231-5. PubMed ID: 3954944
[TBL] [Abstract][Full Text] [Related]
30. In situ detection of c-myc mRNA in adenocarcinomas, adenomas, and mucosa of human colon.
Mariani-Costantini R; Theillet C; Hutzell P; Merlo G; Schlom J; Callahan R
J Histochem Cytochem; 1989 Mar; 37(3):293-8. PubMed ID: 2645359
[TBL] [Abstract][Full Text] [Related]
31. Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors.
Melhem MF; Meisler AI; Finley GG; Bryce WH; Jones MO; Tribby II; Pipas JM; Koski RA
Cancer Res; 1992 Nov; 52(21):5853-64. PubMed ID: 1394214
[TBL] [Abstract][Full Text] [Related]
32. Oncogene-mediated transformation of fetal rat colon in vitro.
Pories S; Jaros K; Steele G; Pauley A; Summerhayes IC
Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
[TBL] [Abstract][Full Text] [Related]
33. [Mutation, loss of heterozygosity, and expression of tumor suppressor gene ING1 in sporadic colorectal carcinoma].
Wei JB; Chen LS; Gao F
Ai Zheng; 2005 Feb; 24(2):141-4. PubMed ID: 15694021
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of c-myc proto-oncogene in primary human breast carcinomas.
Pavelic ZP; Steele P; Preisler HD
Anticancer Res; 1991; 11(4):1421-7. PubMed ID: 1660688
[TBL] [Abstract][Full Text] [Related]
35. Expression of protooncogenes c-fos and c-myc in healing of gastric mucosal stress ulcers.
Wang JY; Johnson LR
Am J Physiol; 1994 May; 266(5 Pt 1):G878-86. PubMed ID: 8203532
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of elongation factor-1gamma protein in colorectal carcinoma.
Mathur S; Cleary KR; Inamdar N; Kim YH; Steck P; Frazier ML
Cancer; 1998 Mar; 82(5):816-21. PubMed ID: 9486568
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray.
Xie D; Sham JS; Zeng WF; Lin HL; Che LH; Wu HX; Wen JM; Fang Y; Hu L; Guan XY
Int J Cancer; 2003 Dec; 107(6):896-902. PubMed ID: 14601048
[TBL] [Abstract][Full Text] [Related]
38. p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines.
Chang H; Blondal JA; Benchimol S; Minden MD; Messner HA
Leuk Lymphoma; 1995 Sep; 19(1-2):165-71. PubMed ID: 8574164
[TBL] [Abstract][Full Text] [Related]
39. Ploidy and proliferation patterns in colo-rectal adenocarcinomas related to Dukes' classification and to histopathological differentiation. A flow-cytometric DNA study.
Tribukait B; Hammarberg C; Rubio C
Acta Pathol Microbiol Immunol Scand A; 1983 Mar; 91(2):89-95. PubMed ID: 6846020
[TBL] [Abstract][Full Text] [Related]
40. The expression of the apoptosis-suppressive gene bcl-2 in the tissue of colon carcinoma.
Huang W; Yao X
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(3):218-20. PubMed ID: 12658808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
